Confounders in the Interpretation of Paraneoplastic and Neuronal Autoantibody Panels.

[1]  J. Mills,et al.  Reader response: Unintended consequences of Mayo paraneoplastic evaluations , 2019, Neurology.

[2]  B. Callaghan.  Author response: Unintended consequences of Mayo paraneoplastic evaluations , 2019, Neurology.

[3]  H. Abboud,et al.  Iatrogenic CNS demyelination in the era of modern biologics , 2019, Multiple sclerosis.

[4]  M. Banerjee,et al.  Unintended consequences of Mayo paraneoplastic evaluations , 2018, Neurology.

[5]  J. Britton,et al.  Predictors of neural-specific autoantibodies and immunotherapy response in patients with cognitive dysfunction , 2018, Journal of Neuroimmunology.

[6]  Luay Shayya,et al.  Low specificity of voltage-gated calcium channel antibodies in Lambert–Eaton myasthenic syndrome: a call for caution , 2018, Journal of Neurology.

[7]  J. Probasco,et al.  Neuronal autoantibodies: differentiating clinically relevant and clinically irrelevant results , 2017, Journal of Neurology.

[8]  Luay Shayya,et al.  Clinical utility of seropositive voltage-gated potassium channel–complex antibody , 2016, Neurology. Clinical practice.

[9]  B. Jackson,et al.  Autoantibody diversity in paraneoplastic syndromes and related disorders: The need for a more guided screening approach. , 2016, Clinica chimica acta; international journal of clinical chemistry.

[10]  C. Hoogenraad,et al.  Detection and Characterization of Autoantibodies to Neuronal Cell-Surface Antigens in the Central Nervous System , 2016, Front. Mol. Neurosci..

[11]  P. S. Sillevis Smitt,et al.  The relevance of VGKC positivity in the absence of LGI1 and Caspr2 antibodies , 2016, Neurology.

[12]  A. Venkatesan,et al.  A clinical approach to diagnosis of autoimmune encephalitis , 2016, The Lancet Neurology.

[13]  Yuebing Li,et al.  Clinical experience of seropositive ganglionic acetylcholine receptor antibody in a tertiary neurology referral center , 2015, Muscle & nerve.

[14]  D. Kullmann,et al.  Clinical relevance of serum antibodies to extracellular N-methyl-d-aspartate receptor epitopes , 2014, Journal of Neurology, Neurosurgery & Psychiatry.

[15]  R. Balice-Gordon,et al.  Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study , 2014, The Lancet Neurology.

[16]  J. Schott,et al.  Clinical relevance of positive voltage-gated potassium channel (VGKC)-complex antibodies: experience from a tertiary referral centre , 2013, Journal of Neurology, Neurosurgery & Psychiatry.

[17]  J. Dalmau,et al.  Clinical neuropathology practice guide 5-2012: Updated guideline for the diagnosis of anti-neuronal antibodies , 2012, Clinical neuropathology.

[18]  M. Rosenfeld,et al.  Paraneoplastic syndromes of the CNS , 2008, The Lancet Neurology.

[19]  E. Benarroch,et al.  Glutamic acid decarboxylase autoimmunity with brainstem, extrapyramidal, and spinal cord dysfunction. , 2006, Mayo Clinic proceedings.